Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Income Statement [Abstract]
Net Sales	$ 2,077.3	$ 1,942.0	$ 3,986.4	$ 3,831.2
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 592.2	$ 553.6	$ 1,142.0	$ 1,065.9
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 160.6	$ 144.0	$ 311.6	$ 286.1
Research and development	113.3	109.4	223.9	217.4
Selling, general and administrative	814.8	737.1	1,573.5	1,473.2
Restructuring and other cost reduction initiatives	17.5	41.5	53.5	165.9
Acquisition, integration, divestiture and related	78.9	5.2	89.5	5.5
Operating expenses	1,777.3	1,590.8	3,394.0	3,214.0
Operating Profit	300.0	351.3	592.3	617.2
Other income, net	3.9	2.0	6.9	1.9
Interest expense, net	(79.3)	(51.1)	(145.5)	(101.8)
Earnings before income taxes	224.6	302.2	453.6	517.3
Provision for income taxes	71.2	59.1	117.6	101.4
Net Earnings	153.4	243.1	336.0	415.9
Less: Net earnings attributable to noncontrolling interest	0.6	0.3	1.1	0.7
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 152.8	$ 242.8	$ 334.9	$ 415.2
Earnings Per Common Share
Basic	$ 0.77	$ 1.18	$ 1.69	$ 2.02
Diluted	$ 0.77	$ 1.18	$ 1.68	$ 2.01
Weighted Average Common Shares Outstanding
Basic	197.9	205.7	198.4	205.4
Diluted	198.3	206.4	199.0	206.3